Details of the Drug-Related molecule(s) Activity Atlas
General Information of Drug (ID: DM26PRD)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
71620-89-8; (2r)-2-[(R)-(2-Ethoxyphenoxy)(Phenyl)methyl]morpholine; Morpholine, 2-[(2-ethoxyphenoxy)phenylmethyl]-, (R*,R*)-; Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-; Reboxetine [INN:BAN]; Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-rel-; HSDB 7701; Edronax (TN); (R,R)-Reboxetine; AC1L2RJ0; SCHEMBL34533; CHEMBL383921; DTXSID1048257; MolPort-005-943-618; CHEBI:135342; ZINC3996032; BCP12060; AKOS015966368; DB00234; AN-34535; AK431803; AJ-47614
|
|||||
| Therapeutic Class |
Antidepressants
|
|||||
| Cross-matching ID | ||||||
Molecule-level Activity Landscape of This Drug
|
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
